| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.643 | 0.005 | 0.675 | Anticonvulsant | 0.675 0.005 CID_71315019 0.641 0.005 CID_10403087 | CID_71315019 | |
| 0.62 | 0.016 | 0.62 | Aldehyde oxidase inhibitor | 0.437 0.042 CID_71315019 0.33 0.059 CID_10403087 | ||
| 0.507 | 0.022 | 0.507 | Spasmolytic | 0.324 0.061 CID_71315019 0.363 0.049 CID_10403087 | ||
| 0.494 | 0.016 | 0.509 | Cardiotonic | 0.509 0.014 CID_71315019 0.427 0.024 CID_10403087 | CID_71315019 | |
| 0.454 | 0.023 | 0.454 | Vasodilator, coronary | 0.314 0.076 CID_71315019 0.36 0.05 CID_10403087 | ||
| 0.383 | 0.005 | 0.383 | Nav1.1 sodium channel blocker | 0.301 0.008 CID_71315019 0.357 0.005 CID_10403087 | ||
| 0.379 | 0.005 | 0.379 | Calcium channel blocker | 0.352 0.006 CID_71315019 0.327 0.008 CID_10403087 | ||
| 0.334 | 0.012 | 0.334 | Nav1.2 sodium channel blocker | 0.141 0.063 CID_71315019 0.314 0.014 CID_10403087 | ||
| 0.347 | 0.046 | 0.347 | Hypoxia-inducible factor 1 alpha inhibitor | 0.315 0.059 CID_10403087 | ||
| 0.301 | 0.006 | 0.301 | Nav1.6 sodium channel blocker | 0.162 0.042 CID_71315019 0.206 0.017 CID_10403087 | ||
| 0.299 | 0.014 | 0.403 | Antipruritic | 0.403 0.006 CID_71315019 0.293 0.015 CID_10403087 | CID_71315019 | |
| 0.35 | 0.074 | 0.371 | Vasodilator, peripheral | 0.371 0.065 CID_71315019 0.26 0.12 CID_10403087 | CID_71315019 | |
| 0.284 | 0.007 | 0.363 | Histamine H1 receptor antagonist | 0.363 0.005 CID_71315019 0.164 0.021 CID_10403087 | CID_71315019 | |
| 0.305 | 0.04 | 0.305 | Cyclic AMP phosphodiesterase inhibitor | 0.185 0.106 CID_10403087 | ||
| 0.251 | 0.004 | 0.251 | Sphingomyelinase inhibitor | 0.151 0.024 CID_71315019 0.21 0.008 CID_10403087 | ||
| 0.264 | 0.017 | 0.264 | Anesthetic local | 0.103 0.08 CID_71315019 0.234 0.024 CID_10403087 | ||
| 0.242 | 0.015 | 0.314 | Antihistaminic | 0.314 0.009 CID_71315019 0.19 0.022 CID_10403087 | CID_71315019 | |
| 0.263 | 0.038 | 0.275 | P-glycoprotein inhibitor | 0.275 0.034 CID_71315019 0.219 0.054 CID_10403087 | CID_71315019 | |
| 0.276 | 0.057 | 0.276 | Vasodilator | 0.208 0.099 CID_71315019 0.233 0.08 CID_10403087 | ||
| 0.23 | 0.015 | 0.273 | Histamine antagonist | 0.273 0.011 CID_71315019 0.178 0.023 CID_10403087 | CID_71315019 | |
| 0.219 | 0.019 | 0.219 | Nav1.3 sodium channel blocker | 0.178 0.033 CID_10403087 | ||
| 0.335 | 0.147 | 0.335 | MAP kinase 1 inhibitor | 0.317 0.162 CID_10403087 | ||
| 0.34 | 0.154 | 0.34 | Caspase 9 stimulant | 0.305 0.189 CID_10403087 | ||
| 0.191 | 0.006 | 0.191 | Calcium channel L-type blocker | 0.135 0.013 CID_71315019 0.186 0.006 CID_10403087 | ||
| 0.3 | 0.123 | 0.3 | Histamine release inhibitor | 0.222 0.178 CID_10403087 | ||
| 0.188 | 0.02 | 0.188 | Calcium channel (voltage-sensitive) blocker | 0.149 0.034 CID_71315019 0.172 0.024 CID_10403087 | ||
| 0.261 | 0.096 | 0.261 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.198 0.16 CID_10403087 | ||
| 0.198 | 0.043 | 0.198 | Acetylcholine M1 receptor antagonist | 0.119 0.11 CID_71315019 0.143 0.081 CID_10403087 | ||
| 0.159 | 0.015 | 0.26 | 5 Hydroxytryptamine uptake inhibitor | 0.093 0.029 CID_71315019 0.26 0.008 CID_10403087 | CID_10403087 | |
| 0.222 | 0.081 | 0.222 | Potassium channel (Voltage-sensitive) blocker | 0.185 0.107 CID_71315019 0.171 0.119 CID_10403087 | ||
| 0.164 | 0.023 | 0.164 | Heat shock protein 70 antagonist | 0.131 0.114 CID_71315019 0.149 0.049 CID_10403087 | ||
| 0.217 | 0.081 | 0.217 | HERG channel blocker | 0.181 0.102 CID_71315019 0.158 0.122 CID_10403087 | ||
| 0.156 | 0.023 | 0.169 | Sphingosine 1-phosphate receptor 2 agonist | 0.111 0.071 CID_71315019 0.169 0.018 CID_10403087 | CID_10403087 | |
| 0.171 | 0.037 | 0.171 | Aldehyde dehydrogenase inhibitor | 0.128 0.063 CID_71315019 0.114 0.077 CID_10403087 | ||
| 0.172 | 0.043 | 0.172 | NADPH oxidase inhibitor | 0.138 0.063 CID_10403087 | ||
| 0.139 | 0.011 | 0.217 | Adrenaline uptake inhibitor | 0.092 0.021 CID_71315019 0.217 0.005 CID_10403087 | CID_10403087 | |
| 0.179 | 0.057 | 0.179 | Cytidine deaminase inhibitor | 0.154 0.073 CID_10403087 | ||
| 0.148 | 0.03 | 0.263 | Mediator release inhibitor | 0.263 0.009 CID_71315019 0.162 0.024 CID_10403087 | CID_71315019 | |
| 0.143 | 0.025 | 0.143 | Calcium antagonist | |||
| 0.161 | 0.045 | 0.161 | MAP3K9 inhibitor | 0.132 0.091 CID_71315019 0.157 0.05 CID_10403087 | ||
| 0.146 | 0.033 | 0.146 | Photosensitizer | 0.099 0.09 CID_10403087 | ||
| 0.236 | 0.123 | 0.236 | Ca(v)3.3 blocker | 0.206 0.179 CID_10403087 | ||
| 0.135 | 0.026 | 0.135 | Alcohol dehydrogenase inhibitor | 0.114 0.039 CID_71315019 0.106 0.046 CID_10403087 | ||
| 0.128 | 0.021 | 0.128 | 5 Hydroxytryptamine 1F antagonist | 0.084 0.04 CID_10403087 | ||
| 0.149 | 0.044 | 0.149 | Ca2+-transporting ATPase inhibitor | 0.139 0.078 CID_10403087 | ||
| 0.135 | 0.033 | 0.153 | Protein kinase C mu inhibitor | 0.153 0.025 CID_10403087 | CID_10403087 | |
| 0.122 | 0.02 | 0.166 | Histamine H2 receptor antagonist | 0.082 0.062 CID_71315019 0.166 0.007 CID_10403087 | CID_10403087 | |
| 0.131 | 0.032 | 0.131 | Uric acid excretion stimulant | 0.121 0.038 CID_71315019 0.105 0.049 CID_10403087 | ||
| 0.131 | 0.032 | 0.195 | Nitric-oxide synthase inhibitor | 0.195 0.01 CID_10403087 | CID_10403087 | |
| 0.105 | 0.013 | 0.109 | Vanilloid 4 agonist | 0.086 0.031 CID_71315019 0.109 0.011 CID_10403087 | CID_10403087 | |
| 0.183 | 0.098 | 0.186 | 5 Hydroxytryptamine 3E antagonist | 0.17 0.136 CID_71315019 0.186 0.091 CID_10403087 | CID_10403087 | |
| 0.12 | 0.036 | 0.12 | 5 Hydroxytryptamine 2C antagonist | 0.088 0.054 CID_10403087 | ||
| 0.103 | 0.021 | 0.103 | Estrogen-related receptor beta agonist | 0.09 0.04 CID_71315019 0.083 0.058 CID_10403087 | ||
| 0.131 | 0.051 | 0.131 | Calcium channel N-type blocker | 0.123 0.06 CID_71315019 0.123 0.059 CID_10403087 | ||
| 0.113 | 0.035 | 0.113 | Histamine N-methyltransferase inhibitor | |||
| 0.234 | 0.161 | 0.3 | Calpain 2 inhibitor | 0.3 0.114 CID_10403087 | CID_10403087 | |
| 0.117 | 0.046 | 0.117 | Antiadrenergic | 0.108 0.051 CID_10403087 | ||
| 0.096 | 0.026 | 0.096 | Dopamine D1 antagonist | 0.063 0.047 CID_10403087 | ||
| 0.11 | 0.042 | 0.117 | Lanosterol 14 alpha demethylase inhibitor | 0.117 0.033 CID_10403087 | CID_10403087 | |
| 0.124 | 0.055 | 0.133 | Alpha 2b adrenoreceptor antagonist | 0.133 0.048 CID_10403087 | CID_10403087 | |
| 0.13 | 0.065 | 0.13 | Cholinergic antagonist | |||
| 0.124 | 0.063 | 0.124 | Acetylcholine muscarinic antagonist | |||
| 0.078 | 0.018 | 0.095 | Dopamine transporter inhibitor | 0.052 0.03 CID_71315019 0.095 0.013 CID_10403087 | CID_10403087 | |
| 0.154 | 0.094 | 0.187 | ATPase inhibitor | 0.187 0.049 CID_10403087 | CID_10403087 | |
| 0.119 | 0.059 | 0.119 | 5 Hydroxytryptamine 2 antagonist | 0.106 0.068 CID_10403087 | ||
| 0.091 | 0.035 | 0.091 | CC chemokine 5 receptor agonist | 0.078 0.07 CID_71315019 0.083 0.054 CID_10403087 | ||
| 0.116 | 0.06 | 0.135 | GABA receptor agonist | 0.135 0.045 CID_71315019 | CID_71315019 | |
| 0.096 | 0.041 | 0.106 | GABA A receptor agonist | 0.106 0.033 CID_71315019 0.08 0.063 CID_10403087 | CID_71315019 | |
| 0.101 | 0.046 | 0.101 | 5 Hydroxytryptamine 2A antagonist | 0.075 0.063 CID_10403087 | ||
| 0.138 | 0.084 | 0.167 | Adenylate cyclase stimulant | 0.167 0.039 CID_10403087 | CID_10403087 | |
| 0.079 | 0.033 | 0.079 | Dopamine D3 antagonist | 0.053 0.052 CID_10403087 | ||
| 0.165 | 0.12 | 0.204 | Potassium channel blocker | 0.204 0.09 CID_71315019 | CID_71315019 | |
| 0.162 | 0.117 | 0.162 | Growth factor agonist | |||
| 0.125 | 0.081 | 0.188 | Toll-Like receptor 9 antagonist | 0.185 0.042 CID_71315019 0.188 0.041 CID_10403087 | CID_10403087 | |
| 0.178 | 0.138 | 0.178 | Calpain inhibitor | 0.175 0.142 CID_10403087 | ||
| 0.086 | 0.048 | 0.086 | Caspase 7 inhibitor | 0.081 0.059 CID_10403087 | ||
| 0.097 | 0.06 | 0.097 | DNA directed RNA polymerase inhibitor | 0.09 0.07 CID_71315019 0.092 0.067 CID_10403087 | ||
| 0.094 | 0.057 | 0.094 | Adrenaline antagonist | 0.092 0.059 CID_10403087 | ||
| 0.113 | 0.077 | 0.113 | Acetylcholine antagonist | |||
| 0.098 | 0.063 | 0.098 | Butyrylcholinesterase inhibitor | |||
| 0.046 | 0.011 | 0.046 | ATM kinase inhibitor | 0.044 0.012 CID_10403087 | ||
| 0.184 | 0.15 | 0.184 | Neuropeptide Y2 antagonist | |||
| 0.055 | 0.023 | 0.055 | Farnesyltransferase inhibitor | 0.042 0.038 CID_71315019 0.045 0.034 CID_10403087 | ||
| 0.093 | 0.061 | 0.093 | Alpha adrenoreceptor antagonist | 0.084 0.068 CID_10403087 | ||
| 0.128 | 0.097 | 0.134 | Diuretic | 0.134 0.091 CID_10403087 | CID_10403087 | |
| 0.051 | 0.02 | 0.051 | Phosphodiesterase 6C inhibitor | 0.049 0.025 CID_71315019 0.045 0.037 CID_10403087 | ||
| 0.094 | 0.065 | 0.111 | Interleukin 1 beta converting enzyme inhibitor | 0.111 0.044 CID_10403087 | CID_10403087 | |
| 0.159 | 0.132 | 0.159 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.127 | 0.101 | 0.127 | Thiol protease inhibitor | |||
| 0.054 | 0.029 | 0.054 | Antiviral (Hepatitis D) | |||
| 0.056 | 0.033 | 0.072 | Elastase inhibitor | 0.072 0.02 CID_71315019 | CID_71315019 | |
| 0.068 | 0.045 | 0.068 | Potassium channel (ATP-sensitive) blocker | 0.068 0.044 CID_10403087 | ||
| 0.06 | 0.037 | 0.06 | Protein kinase C theta inhibitor | 0.054 0.046 CID_10403087 | ||
| 0.035 | 0.017 | 0.048 | Endothelial nitric-oxide synthase inhibitor | 0.048 0.01 CID_10403087 | CID_10403087 | |
| 0.055 | 0.037 | 0.064 | Myc inhibitor | 0.064 0.024 CID_10403087 | CID_10403087 | |
| 0.194 | 0.175 | 0.207 | Transcription factor NF kappa B inhibitor | 0.207 0.162 CID_10403087 | CID_10403087 | |
| 0.037 | 0.019 | 0.057 | Benzodiazepine receptor peripheral-type antagonist | 0.057 0.005 CID_71315019 | CID_71315019 | |
| 0.113 | 0.097 | 0.156 | Toll-Like receptor antagonist | 0.156 0.051 CID_71315019 0.115 0.092 CID_10403087 | CID_71315019 | |
| 0.07 | 0.054 | 0.07 | Dopamine antagonist | |||
| 0.074 | 0.061 | 0.074 | Acetylcholine nicotinic antagonist | |||
| 0.078 | 0.066 | 0.078 | Ca(v)3.1 blocker | |||
| 0.222 | 0.212 | 0.252 | Analgesic | 0.252 0.181 CID_10403087 | CID_10403087 | |
| 0.096 | 0.086 | 0.096 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.092 | 0.083 | 0.092 | DNA intercalator | |||
| 0.07 | 0.062 | 0.076 | Potassium channel (Tandem pore domain) blocker | 0.076 0.046 CID_10403087 | CID_10403087 | |
| 0.032 | 0.024 | 0.032 | Vanilloid 4 antagonist | |||
| 0.142 | 0.138 | 0.152 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.152 0.125 CID_10403087 | CID_10403087 | |
| 0.091 | 0.087 | 0.091 | 5 Hydroxytryptamine antagonist | |||
| 0.085 | 0.082 | 0.085 | MAP kinase kinase kinase inhibitor | |||
| 0.184 | 0.182 | 0.202 | Insulysin inhibitor | 0.202 0.153 CID_10403087 | CID_10403087 | |
| 0.057 | 0.056 | 0.057 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.044 | 0.043 | 0.047 | Benzodiazepine antagonist | 0.047 0.033 CID_71315019 | CID_71315019 | |
| 0.204 | 0.209 | 0.225 | 15-Lipoxygenase inhibitor | 0.225 0.187 CID_10403087 | CID_10403087 | |
| 0.048 | 0.054 | 0.085 | Cannabinoid CB1 receptor agonist | 0.085 0.026 CID_71315019 0.056 0.046 CID_10403087 | CID_71315019 | |
| 0.027 | 0.04 | 0.036 | RNA-directed RNA polymerase inhibitor | 0.036 0.022 CID_10403087 | CID_10403087 | |
| 0.04 | 0.055 | 0.055 | Potassium channel (ATP-sensitive) activator | 0.055 0.021 CID_71315019 0.046 0.038 CID_10403087 | CID_71315019 | |
| 0.042 | 0.057 | 0.058 | Potassium channel (Inward rectifier) activator | 0.058 0.022 CID_71315019 0.048 0.04 CID_10403087 | CID_71315019 | |
| 0.047 | 0.063 | 0.066 | Cannabinoid receptor agonist | 0.066 0.044 CID_71315019 0.058 0.05 CID_10403087 | CID_71315019 | |
| 0.188 | 0.204 | 0.203 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.203 0.158 CID_10403087 | CID_10403087 | |
| 0.071 | 0.095 | 0.113 | Potassium channel activator | 0.092 0.058 CID_71315019 0.113 0.037 CID_10403087 | CID_10403087 | |
| 0.035 | 0.066 | 0.048 | Potassium channel (Inward rectifier) blocker | 0.048 0.037 CID_71315019 | CID_71315019 | |
| 0.122 | 0.155 | 0.14 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.14 0.122 CID_10403087 | CID_10403087 | |
| 0.053 | 0.096 | 0.072 | Secretase beta inhibitor | 0.072 0.046 CID_10403087 | CID_10403087 | |
| 0.16 | 0.208 | 0.193 | Gastrin inhibitor | 0.193 0.16 CID_10403087 | CID_10403087 | |
| 0.059 | 0.112 | 0.103 | Inducible nitric-oxide synthase inhibitor | 0.103 0.035 CID_10403087 | CID_10403087 | |
| 0.033 | 0.111 | 0.068 | Toll-Like receptor 7 antagonist | 0.068 0.048 CID_10403087 | CID_10403087 | |
| 0.1 | 0.199 | 0.131 | Sphingosine 1-phosphate receptor 5 antagonist | 0.131 0.098 CID_71315019 | CID_71315019 | |
| 0.126 | 0.239 | 0.229 | Thyroid hormone beta antagonist | 0.229 0.132 CID_71315019 | CID_71315019 | |
| 0.118 | 0.253 | 0.225 | Thyroid hormone antagonist | 0.225 0.141 CID_71315019 | CID_71315019 | |
| 0.102 | 0.282 | 0.221 | Beta lactamase inhibitor | 0.221 0.172 CID_71315019 | CID_71315019 | |
| 0.009 | 0.204 | 0.075 | Beta tubulin antagonist | 0.075 0.032 CID_71315019 | CID_71315019 | |
| 0.022 | 0.355 | 0.058 | Factor III inhibitor | 0.058 0.019 CID_10403087 | CID_10403087 | |
| 0.05 | 0.411 | 0.175 | Tumour necrosis factor alpha release inhibitor | 0.175 0.13 CID_71315019 | CID_71315019 | |
| 0.012 | 0.418 | 0.061 | Leukotriene synthesis inhibitor | 0.061 0.054 CID_71315019 | CID_71315019 | |
| 0.031 | 0.578 | 0.104 | Toll-Like receptor 3 antagonist | 0.104 0.045 CID_10403087 | CID_10403087 | |
| 0.02 | 0.645 | 0.134 | Interleukin 1 antagonist | 0.134 0.072 CID_71315019 | CID_71315019 | |
| 0.084 | 0.719 | 0.424 | Calcium channel L-type activator | 0.424 0.066 CID_10403087 | CID_10403087 | |
| 0.016 | 0.806 | 0.132 | Interleukin 1b antagonist | 0.132 0.053 CID_71315019 | CID_71315019 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |